**Question:** Drug of choice for malaria in pregnancy is:

**Correct Answer:** **A. Artemisinin-based Combination Therapy (ACT)**

**Core Concept:** Malaria in pregnancy is a significant global health concern, particularly in sub-Saharan Africa. Artemisinin-based combination therapy (ACT) is the first-line treatment for uncomplicated malaria in pregnancy, as it efficiently targets the parasite and has a low risk of drug resistance and adverse effects on the mother and fetus.

**Why the Correct Answer is Right:**

Artemisinin-based combination therapy (ACT) is the preferred treatment for malaria in pregnancy due to several reasons:

1. **Efficacy:** ACTs are highly effective against Plasmodium falciparum, the species responsible for severe malaria in pregnancy. They achieve rapid parasite clearance and prevent disease progression.
2. **Low risk of drug resistance:** Unlike some other antimalarial drugs, ACTs have shown to be effective against drug-resistant strains of Plasmodium falciparum, reducing the risk of resistance development.
3. **Reduced maternal and fetal toxicity:** ACTs have a lower risk of causing adverse effects in pregnant women and their fetuses when compared to older antimalarial drugs.

**Why Each Wrong Option is Incorrect:**

1. **Option B (Sulfadoxine-Pyrimethamine):** Although SP is used for prophylaxis in some regions, its efficacy is lower compared to ACTs, and its association with severe neonatal toxicity has led to concerns about its use in pregnancy.
2. **Option C (Quinine):** Quinine is used for severe malaria treatment, but it is not the first-line therapy for uncomplicated malaria in pregnancy due to potential teratogenic effects and slow parasite clearance.
3. **Option D (Mefloquine):** Mefloquine is primarily used for prophylaxis, not as first-line therapy for malaria in pregnancy. It is associated with a higher risk of adverse effects on both the mother and the fetus compared to ACTs.

**Clinical Pearl:**

In malaria endemic regions, it is crucial to provide appropriate antimalarial prophylaxis to pregnant women to prevent malaria complications and adverse outcomes for both the mother and the fetus. The use of ACTs, such as Artemisinin-based combination therapies, ensures effective malaria treatment while minimizing risks to the mother and child.